 Chembio Diagnostics Inc NASDAQ:CEMI submitted an Emergency Use Authorization EUA application to the FDA for the new DPP SARS-CoV-2 Antigen test. The DPP SARS-CoV-2 Antigen test system has been designed to detect COVID-19 antigens in 20 minutes. 